Prognostic value of diastolic wall strain in patients with chronic heart failure with reduced ejection fraction

Yuko Soyama1, Toshiaki Mano2, Akiko Goda1

  • 1Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.

Heart and Vessels
|April 27, 2016
PubMed

Insights

Diastolic wall strain (DWS), a marker of left ventricular stiffness, predicts outcomes in heart failure with reduced ejection fraction (HFrEF) patients on beta blockers. Lower DWS indicates a worse prognosis, independent of other factors.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology

Background:

  • Left ventricular (LV) diastolic dysfunction is key in heart failure with reduced ejection fraction (HFrEF).
  • The prognostic value of LV stiffness, a component of diastolic function, in HFrEF patients receiving adequate beta-blocker therapy is not fully understood.

Purpose of the Study:

  • To assess if diastolic wall strain (DWS), a noninvasive marker of LV stiffness, can predict prognosis in HFrEF patients under chronic beta-blockade.
  • To determine if DWS is an independent prognostic factor in this patient population.

Main Methods:

  • Seventy-five HFrEF patients receiving chronic beta-blocker therapy were enrolled.
  • Echocardiographic parameters, plasma brain natriuretic peptide (BNP), and pulmonary artery wedge pressure (PAWP) were measured.
  • DWS was calculated using M-mode echocardiography: DWS = [(LV posterior wall thickness at end-systole - LVPWT at end-diastole)/LVPWT] at end-systole.

Main Results:

  • DWS did not correlate with other echocardiographic parameters or PAWP.
  • Patients with low DWS had a significantly higher incidence of the primary outcome (HF hospitalization or cardiovascular death) over 7 years (p=0.04).
  • Under sufficient beta-blocker therapy, DWS emerged as an independent predictor of event-free time in multivariate analysis, unlike other echocardiographic parameters.

Conclusions:

  • Impaired LV stiffness, assessed by DWS, is linked to worse outcomes in HFrEF patients on chronic beta-blockade.
  • DWS may serve as an independent prognostic factor in this specific patient group.